Sickle cell disease (SCD) is a pathology caused by a mutative hemoglobin protein that produces rigid, sickle-shaped red blood cells (RBCs). Lifelong complications of SCD include acute veno-occlusive crises (VOCs), whose recurrence takes a significant toll on patients, and end-organ damage. Decreased life expectancy and negative quality of life further burden a patient population that is chiefly comprised of Black individuals. Clinicians in collaboration with a multidisciplinary care team must become knowledgeable on best practices for treating patients with SCD, especially as treatment options largely remain limited to acute crises management. In this CME Outfitters live webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.
- Provider:CME Outfitters, LLC
- Activity Link: https://www.cmeoutfitters.com/activity/bridging-gaps-and-advancing-care-in-sickle-cell-disease-in-the-context-of-drug-therapy/
- Start Date: 2024-12-17 06:00:00
- End Date: 2024-12-17 06:00:00
- Credit Details: IPCE Credits: 1.5 hours
AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine